InvestorsHub Logo

dragon52

03/12/12 8:37 AM

#4986 RE: gibsonnova74 #4978

Newa out... nice. 25 Mil annual sales projected...

Sunpeaks Ventures, Inc. subsidiary Healthcare Distribution Specialists, LLC owns
and markets Clotamin, a specialized over-the-counter multivitamin product
designed exclusively for use by patients also on Warfarin. "By my calculations,
if Sunpeaks is able to penetrate just 5% of the Warfarin market in just the U.S.,
sales for Clotamin could potentially surpass $25 million dollars annually,"
Mackie A. Barch, CEO of Sunpeaks said in a press release.